Thomas Pietschmann
Inventor
Stats
- 0 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 9 US Applications Filed
- 0 Total Citation Count
- Jan 21, 2022 Most Recent Filing
- Sep 8, 2011 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH | 1
| 2012
|
Twincore Zentrum fuer Experimentelle and Klinische Infektionsforschung GmbH | 1
1 | 2011
2012 |
RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG | 1
| 2011
|
Inventor Addresses
Address | Duration |
---|---|
Hannover, DE | Aug 15, 13 - Mar 21, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 6 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0091,214 | 2024 | LONAFARNIB FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | 0 |
11331371 | 2022 | Labyrinthopeptins as anti-viral agents | 0 |
2022/0024,879 | 2022 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | 0 |
2020/0283,848 | 2020 | DIAGNOSTICS AND THERAPY FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS | 0 |
2020/0093,888 | 2020 | LABYRINTHOPEPTINS AS ANTI-VIRAL AGENTS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.